Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
12.10
+2.09 (20.88%)
Jun 2, 2025, 4:00 PM - Market closed

Maze Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
294.37196.8129.1699.92
Cash & Short-Term Investments
294.37196.8129.1699.92
Cash Growth
909.58%574.99%-70.82%-
Prepaid Expenses
5.334.864.956.23
Total Current Assets
299.71201.6734.11106.15
Property, Plant & Equipment
28.829.9234.9841.23
Long-Term Deferred Charges
-4.6--
Other Long-Term Assets
4.344.352.412.58
Total Assets
332.84240.5471.5149.96
Accounts Payable
2.41.942.021.59
Accrued Expenses
11.5414.19.8114.87
Current Portion of Leases
4.674.634.494.32
Total Current Liabilities
18.6220.6716.3220.78
Long-Term Debt
--20.08-
Long-Term Leases
21.152225.0527.73
Other Long-Term Liabilities
1.010.97--
Total Liabilities
40.7743.6461.4548.51
Common Stock
0.04000.02
Additional Paid-In Capital
683.2447.2421.8412.79
Retained Earnings
-391.21-358.43-395.69-295.27
Total Common Equity
292.07-311.18-373.85-282.46
Shareholders' Equity
292.07196.910.05101.44
Total Liabilities & Equity
332.84240.5471.5149.96
Total Debt
25.8226.6349.6232.06
Net Cash (Debt)
268.55170.18-20.4767.86
Net Cash Per Share
28.8762.33-8.9433.76
Filing Date Shares Outstanding
43.843.82.322.01
Total Common Shares Outstanding
43.82.442.322.01
Working Capital
281.0918117.7985.37
Book Value Per Share
6.67-127.72-160.95-140.52
Tangible Book Value
292.07-311.18-373.85-282.46
Tangible Book Value Per Share
6.67-127.72-160.95-140.52
Machinery
-17.3116.4716.08
Construction In Progress
-0.030.06-
Leasehold Improvements
-5.455.365.33
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q